K

Kim L. Mercer

Massachusetts Institute of Technology

ORCID: 0000-0002-8525-483X

Publishes on Cancer-related Molecular Pathways, RNA modifications and cancer, Immunotherapy and Immune Responses. 24 papers and 7k citations.

24Publications
7kTotal Citations

Is this you? Claim your profile.

Add your photo, update your bio, and get notified when your ranking changes.

Top publicationsby citations

Analysis of lung tumor initiation and progression using conditional expression of oncogenic <i>K-ras</i>
Erica L. Jackson, Nicholas A. Willis, Kim L. Mercer et al.|Genes & Development|2001
Cited by 2kOpen Access

Adenocarcinoma of the lung is the most common form of lung cancer, but the cell of origin and the stages of progression of this tumor type are not well understood. We have developed a new model of lung adenocarcinoma in mice harboring a conditionally activatable allele of oncogenic K-ras. Here we show that the use of a recombinant adenovirus expressing Cre recombinase (AdenoCre) to induce K-ras G12D expression in the lungs of mice allows control of the timing and multiplicity of tumor initiation. Through the ability to synchronize tumor initiation in these mice, we have been able to characterize the stages of tumor progression. Of particular significance, this system has led to the identification of a new cell type contributing to the development of pulmonary adenocarcinoma.

K-<i>ras</i> is an essential gene in the mouse with partial functional overlap with N-<i>ras</i>
Leisa Johnson, Doron C. Greenbaum, Karen Cichowski et al.|Genes & Development|1997
Cited by 547Open Access

Mammalian ras genes are thought to be critical in the regulation of cellular proliferation and differentiation and are mutated in approximately 30% of all human tumors. However, N-ras and H-ras are nonessential for mouse development. To characterize the normal role of K-ras in growth and development, we have mutated it by gene targeting in the mouse. On an inbred genetic background, embryos homozygous for this mutation die between 12 and 14 days of gestation, with fetal liver defects and evidence of anemia. Thus, K-ras is the only member of the ras gene family essential for mouse embryogenesis. We have also investigated the effect of multiple mutations within the ras gene family. Most animals lacking N-ras function and heterozygous for the K-ras mutation exhibit abnormal hematopoietic development and die between days 10 and 12 of embryogenesis. Thus, partial functional overlap appears to occur within the ras gene family, but K-ras provides a unique and essential function.